
Michael Wilson, MD
My lab employs genomic technologies, including metagenomic next-generation sequencing, immune repertoire sequencing, bulk and single cell transcriptomics and phage display assays for viral and autoantibody detection to better understand the pathophysiology of a variety of neuroinflammatory syndromes ranging from multiple sclerosis to infectious and autoimmune meningitis and encephalitis. I am a PI on an NIH (NIAID) R01-funded study that is employing a novel combination of metagenomic next-generation sequencing coupled with a CRISPR/Cas9-based targeted enrichment method to detect TB and antimicrobial resistance genes in cerebrospinal fluid from patients with suspected TB meningitis while also performing longitudinal host transcriptional profiling to better understand TB meningitis pathogenesis. In addition to my research activities, I am a board-certified neurologist with subspecialty training in neuro-infectious diseases who sees patients with complications of neurological infections and other neuroinflammatory syndromes at the UCSF Multiple Sclerosis and Neuroinflammation Center.
Wilson lab: https://wilsonlab.ucsf.edu/